Episode Details
Back to EpisodesE117: Inebilizumab for IgG4-RD (MITIGATE)
Episode 118
Published 1 year, 4 months ago
Description
New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays everyone!